Frank G. Keller

1.4k total citations
65 papers, 583 citations indexed

About

Frank G. Keller is a scholar working on Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Frank G. Keller has authored 65 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pathology and Forensic Medicine, 25 papers in Public Health, Environmental and Occupational Health and 23 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Frank G. Keller's work include Lymphoma Diagnosis and Treatment (30 papers), Acute Lymphoblastic Leukemia research (21 papers) and Childhood Cancer Survivors' Quality of Life (20 papers). Frank G. Keller is often cited by papers focused on Lymphoma Diagnosis and Treatment (30 papers), Acute Lymphoblastic Leukemia research (21 papers) and Childhood Cancer Survivors' Quality of Life (20 papers). Frank G. Keller collaborates with scholars based in United States, Canada and Germany. Frank G. Keller's co-authors include Kara M. Kelly, Sharon M. Castellino, Cindy L. Schwartz, Lu Chen, S. Schwender, R. Großmann, David Hodgson, Kathleen M. McCarten, Louis S. Constine and Qinglin Pei and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Frank G. Keller

61 papers receiving 571 citations

Peers

Countries citing papers authored by Frank G. Keller

Since Specialization

Citations

This map shows the geographic impact of Frank G. Keller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank G. Keller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank G. Keller more than expected).

Fields of papers citing papers by Frank G. Keller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank G. Keller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank G. Keller. The network helps show where Frank G. Keller may publish in the future.

Co-authorship network of co-authors of Frank G. Keller

This figure shows the co-authorship network connecting the top 25 collaborators of Frank G. Keller. A scholar is included among the top collaborators of Frank G. Keller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank G. Keller. Frank G. Keller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Alternative mRNA splicing in anthracycline-induced cardiomyopathy – a COG-ALTE03N1 report 2025 ·Cardio-Oncology ·Purnima Singh, David K. Crossman, Changde Cheng, Patrick J. Trainor, Noha Sharafeldin, Xuexia Wang, (unknown), Lindsey Hageman, Saro H. Armenian, Frank M. Balis, Douglas S. Hawkins, Frank G. Keller, Melissa M. Hudson, Joseph P. Neglia, Jill P. Ginsberg, Wendy Landier, Smita Bhatia	0
2	Comparison of Contemporary Radiation Therapy Approaches in Combined Modality Treatment on Pediatric High-Risk Classic Hodgkin Lymphoma Study: AHOD 1331 2025 ·International Journal of Radiation OncologyBiologyPhysics ·Bradford S. Hoppe, Raymond B. Mailhot Vega, Lindsay A. Renfro, Qinglin Pei, (unknown), Rahul R. Parikh, Kenneth B. Roberts, Frank G. Keller, Angela Punnett, Susan K. Parsons, Stephan D. Voss, (unknown), Kathleen M. McCarten, Stella Flampouri, Sandy Kessel, Yue Wu, (unknown), Kara M. Kelly, Sharon M. Castellino, David Hodgson	0
3	Transplant-Free Salvage Therapy for Low-Risk Relapsed Pediatric Hodgkin Lymphoma: A Sub-Study of Children’s Oncology Group AHOD 0431 2024 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), (unknown), Lindsay A. Renfro, Yue Wu, (unknown), (unknown), (unknown), Kimberly M. Kelly, (unknown), Frank G. Keller	0
4	A single‐center retrospective review of pediatric cases of progressive transformation of germinal centers 2023 ·Pediatric Blood & Cancer ·Arhanti Sadanand, (unknown), Daniel John Bergsagel, Frank G. Keller	2
5	Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children’s Oncology Group AHOD 1331 study 2023 ·Journal of Patient-Reported Outcomes ·Susan K. Parsons, Angie Mae Rodday, Qinglin Pei, Frank G. Keller, Yue Wu, Tara O. Henderson, David Cella, Kara M. Kelly, Sharon M. Castellino	9
6	Haptoglobin Gene Expression and Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors 2023 ·JACC CardioOncology ·Purnima Singh, David K. Crossman, (unknown), Xuexia Wang, Noha Sharafeldin, Lindsey Hageman, Javier G. Blanco, Paul W. Burridge, Saro H. Armenian, Frank M. Balis, Douglas S. Hawkins, Frank G. Keller, Melissa M. Hudson, Joseph P. Neglia, A. Kim Ritchey, Jill P. Ginsberg, Wendy Landier, Smita Bhatia	6
7	Abstract 6737: Exposure-response and age subgroup analyses to support body-weight (BW) dosing of brentuximab vedotin (BV) in newly diagnosed high-risk classical Hodgkin lymphoma (cHL) in children and young adults (aged 2-21 years [y]): A randomized children’s oncology group phase 3 trial (AHOD1331) 2023 ·Cancer Research ·Zufei Zhang, (unknown), (unknown), Keenan Fenton, (unknown), Shweta Jain, Joy Jiang, Sharon M. Castellino, Kara M. Kelly, Peter D. Cole, Frank G. Keller, Amit X. Garg, Yen Lin Chia	2
8	Importance of Central Imaging Review in a Pediatric Hodgkin Lymphoma Trial Using Positron Emission Tomography Response Adapted Radiation Therapy 2023 ·International Journal of Radiation OncologyBiologyPhysics ·Bradford S. Hoppe, Kathleen M. McCarten, Qinglin Pei, Sandy Kessel, Adina Alazraki, Joyce Mhlanga, Hollie Lai, (unknown), David Hodgson, Kenneth B. Roberts, (unknown), Frank G. Keller, Stephan D. Voss, Yue Wu, Steve Y. Cho, Kara M. Kelly, Sharon M. Castellino	3
9	Characteristics and outcomes of pediatric oncology patients at risk for guardians declining transfusion of blood components 2022 ·Cancer Reports ·(unknown), Nicholas P. DeGroote, Frank G. Keller, Katharine E. Brock, Daniel John Bergsagel, Tamara P. Miller, (unknown), Ross M. Fasano, Satheesh Chonat, Sharon M. Castellino	1
10	Very late recurrence of B-cell acute lymphoblastic leukemia masquerading as a pituitary tumor 2020 ·Pediatric Hematology and Oncology ·(unknown), Frank G. Keller, Himalee S. Sabnis, Briana C. Patterson, (unknown), Jason H. Peragallo, Valérie Biousse, Daniel S. Wechsler	2
11	A strategy to reduce cumulative anthracycline exposure in low-risk pediatric acute myeloid leukemia while maintaining favorable outcomes 2020 ·Leukemia Research ·Himalee S. Sabnis, Katherine A. Minson, (unknown), Kristen E. Allen, (unknown), Todd M. Cooper, William G. Woods, Sharon M. Castellino, Frank G. Keller	2
12	Premedication and Longer Infusion Time Do Not Reduce the Incidence of Hypersensitivity Reactions to Pegaspargase 2020 ·Blood ·Catherine Hughes, (unknown), (unknown), James P. Hughes, Frank G. Keller, Tamara P. Miller, Sharon M. Castellino, Glen Lew	3
13	Lifelong disease burden of chemotherapy in Hodgkin lymphoma (HL): A simulation study from the St. Jude Lifetime (SJLIFE) Cohort and HL International Study for Individual Care (HoLISTIC). 2020 ·Journal of Clinical Oncology ·Susan K. Parsons, Nickhill Bhakta, Angie Mae Rodday, (unknown), Marc André, Massimo Federico, Jonathan W. Friedberg, Debra L. Friedman, Andrea Gallamini, Annette E. Hay, Brad S. Kahl, Frank G. Keller, Kara M. Kelly, Ralph M. Meyer, John Raemaekers, Leslie L. Robison, Melissa M. Hudson, Joshua T. Cohen, Andrew M. Evens, F. Lennie Wong	2
14	The Hodgkin lymphoma international study for individual care (HoLISTIC): Enhancing decision making in pediatric and adult Hodgkin lymphoma (HL). 2020 ·Journal of Clinical Oncology ·Susan K. Parsons, Angie Mae Rodday, (unknown), Marc André, Massimo Federico, Jonathan W. Friedberg, Debra L. Friedman, Andrea Gallamini, Annette E. Hay, Peter Hoskin, Peter Johnson, Brad S. Kahl, Frank G. Keller, Kara M. Kelly, Ralph M. Meyer, John Radford, John Raemaekers, Pier Luigi Zinzani, Joshua T. Cohen, Andrew M. Evens	1
15	Early T‐Cell Precursor Acute Lymphoblastic Leukemia in an Infant With an NRAS Q61R Mutation and Clinical Features of Juvenile Myelomonocytic Leukemia 2016 ·Pediatric Blood & Cancer ·Sunil S. Raikar, John D. Scarborough, Himalee S. Sabnis, John Bergsagel, David Wu, Todd M. Cooper, Frank G. Keller, Brent L. Wood, Silvia T. Bunting	3
16	Comparison of Allergic Reactions to Intravenous and Intramuscular Pegaspargase in Children with Acute Lymphoblastic Leukemia 2014 ·Pediatric Hematology and Oncology ·(unknown), (unknown), (unknown), (unknown), Scott Gillespie, Courtney McCracken, Frank G. Keller, Glen Lew	30
17	Children's Oncology Group's 2013 blueprint for research: Hodgkin lymphoma 2012 ·Pediatric Blood & Cancer ·Kara M. Kelly, David Hodgson, Burton Appel, Lu Chen, Peter D. Cole, Terzah M. Horton, Frank G. Keller	33
18	Role of FDG-PET in the Definition of Involved-Field Radiation Therapy and Management for Pediatric Hodgkin's Lymphoma 2010 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), (unknown), Frank G. Keller, Raghuveer Halkar, Michael Goodman, Robert B. Marcus, Natia Esiashvili	16
19	What is the best treatment for children with limited-stage Hodgkin lymphoma? 2009 ·Current Hematologic Malignancy Reports ·Frank G. Keller, Sharon M. Castellino, James B. Nachman	5
20	Response of the Cellular Immune System to Cardiopulmonary Bypass in vivo 1997 ·The Thoracic and Cardiovascular Surgeon ·(unknown), (unknown), S. Schwender, R. Großmann, Frank G. Keller, O. Elert	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact